SCHEMBL8085969

SCHEMBL8085969

COc1nc2cc(Br)cc(CO)c2nc1OC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 4/20 0.40
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PTGES O14684 1/20 0.33
GRM1 Q13255 1/20 0.32
PRNP P04156 1/20 0.31
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5973164 0.85 NQO2 (0.41) NQO2ALDH1A1PTGESPRNPMAPT
SCHEMBL5973831 0.84 NQO2 (0.40) NQO2ALDH1A1PTGESPRNPMAPT
Hydrochloric Acid SCHEMBL8086885 0.83 NQO2 (0.39) NQO2ALDH1A1PTGESPRNPMAPT
SCHEMBL27462046 0.83 NQO2 (0.39) NQO2ALDH1A1PTGESPRNPMAPT
SCHEMBL8614365 0.78 NQO2 (0.35) NQO2PTGES
SCHEMBL27514842 0.77 NQO2 (0.35) NQO2PTGES
SCHEMBL8086903 0.77 KDM4E (0.37) NQO2ALDH1A1KDM4EMAPTMEN1
SCHEMBL27463844 0.77 KDM4E (0.38) NQO2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL27444188 0.77 SLC7A5 (0.40) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL8614375 0.77 GRM1 (0.33) NQO2GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1193968-A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives NOVARTIS AG (CH) 1998-09-23 CN claimed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP claimed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO claimed
CN-1137886-C 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives ��˹��ŵ�� 2004-02-11 CN disclosed
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
CN-1193968-A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives NOVARTIS AG (CH) 1998-09-23 CN disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed